Menu
Recruiting NCT07547176

Amino Acid Oxidation of Whole-Food Protein: a Dose-Response Crossover Trial in Young Adults

No phase Interventional Protein Metabolism

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Food proteins.
Who it may be relevant to
Registry conditions: Protein Metabolism. Basic parameters: 18 years — 35 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Netherlands
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this study is to assess the amino acid oxidation dose-response relationship of ingested whole-food protein in healthy adults. In a randomized, crossover design, 20 young, healthy adult males and females aged 18-35 years, will consume a dinner consisting of 0.32, 0.74, and 1.32 g protein・kg BM-1 (corresponding to 1, 2, and 4 minced beef patties, respectively) during 3 separate experimental trials.The main study endpoint is the amino acid oxidation of ingested protein over a 24-h period.

Interventions

  • Dietary supplement Food proteins
    Dinner meal consisting of minced beef protein.

Primary outcome measures

  • Amino acid oxidation of ingested protein [Time frame: Over the 24 hour timeframe following protein ingestion]
Secondary outcome measures (1)
  • Plasma amino acid response of ingested protein [Time frame: Over the 24 hour timeframe following protein ingestion]

Eligibility criteria

Inclusion criteria

  • Aged between 18-35 years
  • BMI between 18.5-30 kg/m2
  • Healthy, recreationally active (exercise at least once per two weeks and a maximum of four days per week)
  • No physical limitations (i.e., able to perform all activities associated with daily living independently)

Exclusion criteria

  • Smoking
  • Vegan, vegetarian, or does not consume beef protein
  • Diagnosed musculoskeletal disorders
  • Use of any medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications)
  • Chronic use of gastric acid-suppressing medication or anti-coagulants
  • Unstable weight over the last three months
  • Diagnosed GI tract disorders or diseases
  • Blood donation in the past 2 months
  • Females: pregnancy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Basic science

Study locations

Netherlands · 1 center
  • Maastricht University Medical Centre+ — Maastricht

Identifiers

NCT: NCT07547176 · METC 25-011 · NL-009478

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗